Assenagon Asset Management S.A. Has $2.69 Million Holdings in Alignment Healthcare, Inc. $ALHC

Assenagon Asset Management S.A. trimmed its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 91.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 152,846 shares of the company’s stock after selling 1,622,129 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Alignment Healthcare were worth $2,693,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Hudson Bay Capital Management LP bought a new stake in Alignment Healthcare during the 3rd quarter worth approximately $4,581,000. 1492 Capital Management LLC raised its position in Alignment Healthcare by 61.8% in the 4th quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock valued at $6,416,000 after purchasing an additional 124,143 shares during the last quarter. Cinctive Capital Management LP bought a new position in Alignment Healthcare in the 3rd quarter valued at $3,814,000. Picton Mahoney Asset Management bought a new position in Alignment Healthcare in the 3rd quarter valued at $6,873,000. Finally, SG Americas Securities LLC boosted its stake in Alignment Healthcare by 148.5% in the fourth quarter. SG Americas Securities LLC now owns 60,390 shares of the company’s stock worth $1,193,000 after purchasing an additional 36,084 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Stock Up 2.4%

NASDAQ:ALHC opened at $23.81 on Wednesday. The company has a market cap of $4.92 billion, a price-to-earnings ratio of 264.56, a P/E/G ratio of 3.14 and a beta of 1.14. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58. The stock’s fifty day moving average price is $18.87 and its two-hundred day moving average price is $19.64. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.97.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business’s revenue for the quarter was up 33.3% on a year-over-year basis. During the same period last year, the firm earned ($0.05) EPS. On average, analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently commented on ALHC. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. Barclays cut their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. UBS Group upped their price target on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $24.30.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, EVP Joseph S. Konowiecki sold 25,000 shares of the business’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $23.00, for a total transaction of $575,000.00. Following the completion of the sale, the executive vice president directly owned 1,128,816 shares of the company’s stock, valued at approximately $25,962,768. The trade was a 2.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $19.55, for a total transaction of $586,500.00. Following the transaction, the president owned 947,313 shares in the company, valued at approximately $18,519,969.15. The trade was a 3.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,306,051 shares of company stock worth $25,733,006 in the last ninety days. 5.20% of the stock is currently owned by insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.